Publicacións nas que colabora con Lina Badimon Maestro (14)

2022

  1. A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry

    Expert Opinion on Pharmacotherapy, Vol. 23, Núm. 12, pp. 1457-1465

  2. Impact of Integrated Care Management on Clinical Outcomes in Atrial Fibrillation Patients: A Report From the FANTASIIA Registry

    Frontiers in Cardiovascular Medicine, Vol. 9

2021

  1. Relationship between multimorbidity and outcomes in atrial fibrillation

    Experimental Gerontology, Vol. 153

2020

  1. Association of Body Mass Index With Clinical Outcomes in Patients With Atrial Fibrillation: A Report From the FANTASIIA Registry

    Journal of the American Heart Association, Vol. 9, Núm. 1

  2. Direct oral anticoagulants versus vitamin K antagonists in real-world patients with nonvalvular atrial fibrillation. The FANTASIIA study

    Revista Espanola de Cardiologia, Vol. 73, Núm. 1, pp. 14-20

  3. Influence of sex on long-term prognosis in patients with atrial fibrillation treated with oral anticoagulants. Results from the prospective, nationwide FANTASIIA study

    European Journal of Internal Medicine, Vol. 78, pp. 63-68

  4. Relationship of adverse events to quality of anticoagulation control in atrial fibrillation patients with diabetes: real-world data from the FANTASIIA Registry

    Annals of Medicine, Vol. 52, Núm. 6, pp. 300-309

2018

  1. Quality of oral anticoagulation with Vitamin K antagonists in 'real-world' patients with atrial fibrillation: A report from the prospective multicentre FANTASIIA registry

    Europace, Vol. 20, Núm. 9, pp. 1435-1441

  2. Relation of Renal Dysfunction to Quality of Anticoagulation Control in Patients with Atrial Fibrillation: The FANTASIIA Registry

    Thrombosis and Haemostasis, Vol. 118, Núm. 2, pp. 279-287

  3. Relation of quality of anticoagulation control with different management systems among patients with atrial fibrillation: Data from FANTASIIA Registry

    European Journal of Clinical Investigation, Vol. 48, Núm. 5

2016

  1. Current Antiarrhythmic Therapy for Nonvalvular Atrial Fibrillation in Spain. Data from the FANTASIIA Registry

    Revista Espanola de Cardiologia, Vol. 69, Núm. 1, pp. 54-60

  2. Do physicians correctly calculate thromboembolic risk scores? A comparison of concordance between manual and computer-based calculation of CHADS2 and CHA2DS2-VASc scores

    Internal Medicine Journal, Vol. 46, Núm. 5, pp. 583-589

  3. Is the ORBIT bleeding risk score superior to the HAS-BLED score in anticoagulated atrial fibrillation patients?

    Circulation Journal, Vol. 80, Núm. 10, pp. 2102-2108

  4. On the Way to a Better Use of Anticoagulants in Nonvalvular Atrial Fibrillation. Proposed Amendment to the Therapeutic Positioning Report UT/V4/23122013

    Revista Espanola de Cardiologia, Vol. 69, Núm. 6, pp. 551-553